LANDINI, IDA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.068
EU - Europa 3.458
AS - Asia 730
AF - Africa 14
SA - Sud America 2
OC - Oceania 1
Totale 8.273
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.057
PL - Polonia 1.362
RU - Federazione Russa 1.016
IE - Irlanda 294
IT - Italia 285
SE - Svezia 232
SG - Singapore 199
HK - Hong Kong 198
CN - Cina 162
DE - Germania 79
IN - India 63
JO - Giordania 63
FI - Finlandia 50
GB - Regno Unito 41
CH - Svizzera 22
TR - Turchia 22
UA - Ucraina 18
VN - Vietnam 18
AT - Austria 16
BE - Belgio 14
CI - Costa d'Avorio 13
ES - Italia 11
CA - Canada 10
FR - Francia 7
DK - Danimarca 3
NL - Olanda 3
KR - Corea 2
PT - Portogallo 2
CO - Colombia 1
CZ - Repubblica Ceca 1
ID - Indonesia 1
IR - Iran 1
LT - Lituania 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
SC - Seychelles 1
Totale 8.273
Salva come PNG Salva come JPEG
Città #
Warsaw 1.356
Santa Clara 753
Fairfield 445
Chandler 328
Dublin 292
Ashburn 280
Seattle 224
Woodbridge 219
Cambridge 202
Houston 199
Singapore 164
Wilmington 162
Ann Arbor 141
Hong Kong 132
Florence 95
Altamura 85
Lawrence 78
Princeton 69
Beijing 60
Buffalo 51
Boston 43
Bremen 42
Boardman 39
Mumbai 38
Shanghai 38
Jacksonville 32
Medford 30
Falls Church 27
New York 27
Kent 25
Moscow 25
Bern 22
San Diego 19
Vienna 16
Brussels 14
Abidjan 13
Chennai 13
Phoenix 12
Barcelona 11
Hillsboro 11
Izmir 11
Norwalk 11
Dong Ket 10
Council Bluffs 9
Guangzhou 9
Pune 9
Dearborn 8
Helsinki 8
London 8
Los Angeles 7
Toronto 7
Laurel 5
Redwood City 5
Andover 4
Romainville 4
Tappahannock 4
Washington 4
West Jordan 4
Kunming 3
Latina 3
Munich 3
Nanjing 3
Prato 3
Redmond 3
Sesto Fiorentino 3
Sinalunga 3
Turin 3
Wuhan 3
Yubileyny 3
Auburn Hills 2
Città Di Castello 2
Copenhagen 2
Fiesole 2
Frankfurt Am Main 2
Guagnano 2
Hefei 2
Livorno 2
Naples 2
Padova 2
Perugia 2
Philadelphia 2
Poggibonsi 2
Radom 2
Radomsko 2
San Mateo 2
Shenzhen 2
Surrey 2
Torchiarolo 2
Torun 2
Trumbull 2
Zhengzhou 2
Aprilia 1
Arezzo 1
Atlanta 1
Auckland 1
Ayer 1
Baotou 1
Bitola 1
Bogotá 1
Bologna 1
Totale 6.045
Salva come PNG Salva come JPEG
Nome #
In vitro assessment of antibody-conjugated gold nanorods for systemic injections 278
Proteomic Analysis of Ovarian Cancer Cell Responses to Cytotoxic Gold Compounds 276
Gold compounds as anticancer agents: chemistry, cellular pharmacology, and preclinical studies. 271
Emerging drugs in refractory colorectal cancer 265
Effect of the SOD mimetic MnL4 on in vitro and in vivo oxaliplatin toxicity: Possible aid in chemotherapy induced neuropathy 265
Proteomic analysis of the cytotoxic effects induced by the organogold(III) complex Aubipyc in cisplatin-resistant A2780 ovarian cancer cells: further evidence for the glycolytic pathway implication 251
The Inhibitory Effects of HYDAMTIQ, a Novel PARP Inhibitor, on Growth in Human Tumor Cell Lines With Defective DNA Damage Response Pathways. 247
Antiproliferative effects of two gold(I)-N-heterocyclic carbene complexes in A2780 human ovarian cancer cells: A comparative proteomic study 246
Proteomic analysis of A2780/S ovarian cancer cell response to the cytotoxic organogold(III) compound Aubipy(c.) 240
Druggable Targets in Pancreatic Adenocarcinoma 230
MTHFR-1298 A>C (rs1801131) is a predictor of survival in two cohorts of stage II/III colorectal cancer patients treated with adjuvant fluoropyrimidine chemotherapy with or without oxaliplatin 204
Selection and characterization of a human ovarian cancer cell line resistant to auranofin 187
Replacement of the Thiosugar of Auranofin with Iodide Enhances the Anticancer Potency in a Mouse Model of Ovarian Cancer 157
A transcriptomic profile predicts clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 139
Epigenetics and chemoresistance in colorectal cancer: An opportunity for treatment tailoring and novel therapeutic strategies 138
Exploring the biochemical mechanisms of cytotoxic gold compounds: a proteomic study. 135
RNA sequencing reveals PNN and KCNQ1OT1 as predictive biomarkers of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 135
Cellular pharmacology of gemcitabine. 135
Chemistry and Biology of Two Novel Gold(I) Carbene Complexes as Prospective Anticancer Agents 134
Cytotoxic properties of a new organometallic platinum(II) complex and its gold(I) heterobimetallic derivatives. 131
Gold(III) complexes with 2-substituted pyridines as experimental anticancer agents: Solution behavior, reactions with model proteins, antiproliferative properties 123
Identification Of Pharmacogenomic Markers Of Clinical Efficacy In A Dose-Dense Therapy Regimen (R-Chop14) In Diffuse Large B Cell Lymphoma 120
Fluoropyrimidine-related toxicity in gastrointestinal cancer patients. Assessment of risk factors. 119
Structural and solution chemistry, protein binding and antiproliferative profiles of gold(I)/(III) complexes bearing the saccharinato ligand. 114
Role of Genetic Polymorphisms on Response to R-CHOP regimen in Diffuse Large B-cell Lymphoma Patients: an Interim Analysis of a Multicenter Prospective Pharmacogenetic Study 112
Overcoming tumor multidrug resistance using drugs able to evade P-glycoprotein or to exploit its expression 111
The molecular mechanisms of antimetastatic ruthenium compounds explored through DIGE proteomics 109
Identification of potential pharmacogenomic markers of clinical efficacy of 5-fluorouracil in colorectal cancer 107
In vitro antiproliferative activity against human colon cancer cell lines of representative 4-thiazolidinones. Part I. 107
Pharmacological strategies for overcoming multidrug resistance. 102
Size dependent biological profiles of PEGylated gold nanorods 101
Role of genetic polymorphisms on R-CHOP efficacy in diffuse large B-cell lymphoma patients: an interim analysis of a multicenter prospective pharmacogenetics study. 100
Structure, solution chemistry, antiproliferative actions and protein binding properties of non-conventional platinum(II) compounds with sulfur and phosphorus donors. 100
Synthesis, Structural Characterization, Solution Behavior, and in Vitro Antiproliferative Properties of a Series of Gold Complexes with 2-(2'-Pyridyl)benzimidazole as Ligand: Comparisons of Gold(III) versus Gold(I) and Mononuclear versus Binuclear Derivatives 99
Role of ATP-binding cassette transporters in cancer initiation and progression 98
Erratum: The inhibitory effects of HYDAMTIQ, a novel PARP inhibitor, on growth in human tumor cell lines with defective DNA damage response pathways (Oncology Research 25:9 (1441-1451) DOI: 10.3727/096504017X14926854178616) 98
Vinorelbine in non-small cell lung cancer: Real-World data from a single institution experience 95
THE IMPACT OF GENETIC POLYMORPHISMS ON R-CHOP EFFICACY IN DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS: AN INTERIM ANALYSIS OF A MULTICENTER PROSPECTIVE PHARMACOGENETIC STUDY 93
In vitro study on the safety of near infrared laser therapy in its potential application as postmastectomy lymphedema treatment 91
Pharmacological modulation of protein kinase C for overcoming drug resistance in colorectal cancer. Preliminary results of in vitro studies. 89
Global gene expression profile reveals a distinct transcriptomic profile predictive of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 89
Relationships between promoter polymorphisms in the thymidylate synthase gene and mRNA levels in colorectal cancers 87
Pharmacogenomic Markers of Clinical Efficacy in a Dose-Dense Therapy Regimen (R-CHOP14) in Diffuse Large B Cell Lymphoma 87
Identification of pharmacogenomic markers of 5-fluorouracil-based chemotherapy in colorectal cancer 84
Antiangiogenic Drugs as Chemosensitizers in Cancer Therapy 83
Correlation between thymidylate synthase (TS) mRNA expression and TS gene promoter polymorphysms in primary colorectal cancer patients. 80
PNN and KCNQ1OT1 can predict the efficacy of adjuvant fluoropyrimidine-based chemotherapy in colorectal cancer patients 80
Cyclodextrin Inclusion Complexes of Auranofin and Its Iodido Analog: A Chemical and Biological Study 76
Correlation between thymidylate synthase (TS) mRNA expression and TS gene promoter polymorphisms in primary colorectal cancer patients 73
In vitro activity of folate antagonists against methotrexate-resistant CCRF-CEM human T-leukemia sublines and relationships with folate pathway gene expression profiles 69
Thymidylate Synthase (TS) mRNA expression and TS gene promoter polymorphism in primary colorectal cancer (CRC) patients (PTS) receiving post-operative fluorouracil (5-FU)-based chemotherapy (CT) 69
Exploratory Genome-Wide Association Analysis to Identify Pharmacogenetic Determinants of Response to R-CHOP in Diffuse Large B-Cell Lymphoma 68
Sequence-dependent interactions between oxaliplatin and 5-fluorouracil in human colon carcinoma cell lines 67
Pharmacogenomic markers of clinical efficacy in a dose-dense therapy regimen (R-CHOP14) in diffuse large B cell lymphoma: preliminary results 67
Structure-activity relationships in a series of auranofin analogues showing remarkable antiproliferative properties 66
Role of genetic polymorphisms on R-CHOP efficacy in diffuse large B-cell lymphoma patients: an interim analysis of a multicenter prospective pharmacogenetics study. 65
Molecular characterization of established human colorectal carcinoma cell lines (HCT-8) made resistant to 5-fluorouracil (5-FU) by different selective schedules 65
The clinical role of PIK3CA mutations in colorectal cancer 64
Artificial Intelligence Predictive Models of Response to Cytotoxic Chemotherapy Alone or Combined to Targeted Therapy for Metastatic Colorectal Cancer Patients: A Systematic Review and Meta-Analysis 63
Mechanisms of methotrexate (MTX) resistance in human colon carcinoma cells DLD-1 62
Pharmacogenetics in diffuse large B-cell lymphoma treated with R-CHOP: Still an unmet challenge 61
In vitro activity of folate antagonists against methotrexate-resistant CCRF-CEM human T-leukemia sublines and relationships with folate pathway gene expression profiles 59
Identification of pharmacogenomic markers of 5-fluorouracil-based chemotherapy in colorectal cancer 57
Role of Non-Coding RNAs in Colorectal Cancer: Focus on Long Non-Coding RNAs 55
Comparative genomic hybridization study of genetic changes associated with 5-fluorouracil resistance in HCT-8 colon cancer cell lines: correlations with the expression profiles 55
Sequence-dependent interactions between oxaliplatin (OHP) and 5-fluorouracil (5-FU) in human colon carcinoma cell lines 53
Preliminary characterization of methotrexate (MTX) resistance mechanisms in human colon carcinoma cells DLD-1 51
Preliminary characterization of methotrexate (MTX) resistance mechanisms in human colon carcinoma cells DLD-1 46
Mechanisms of methotrexate (MTX) resistance in human colon carcinoma cells DLD-1 44
Multiple mechanisms of methotrexate (MTX) resistance in human colon carcinoma cells DLD-1 43
Sequence-dependent interactions between oxaliplatin and 5-fluorouracil in human colon carcinoma cell lines 41
Targeting z-Crystallin by aspirin restores the sensitivity to cisplatin in resistant A2780 ovarian cancer cells 39
Multiple mechanisms of methotrexate (MTX) resistance in human colon carcinoma cells DLD-1. 38
Validation of single nucleotide polymorphisms potentially related to R-CHOP resistance in diffuse large B-cell lymphoma patients 36
P118 A preliminary study for evaluation of cannabis - chemotherapy interactions on human colon cancer cells 35
Therapeutic drug monitoring for the cancer patient: challenges and opportunities 33
In vitro cell growth inhibitory effects of HYDAMTIQ, a novel PARP inhibitor, on human tumor cell lines with defective DNA damage response pathways 28
Role of Non-Coding RNAs in Colorectal Cancer: Focus on Long Non-Coding RNAs 16
null 2
Totale 8.408
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.046
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.046
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020978 0 0 0 0 158 145 148 161 131 100 117 18
2020/2021837 75 74 23 86 70 95 58 57 77 131 49 42
2021/2022511 13 40 39 17 22 28 36 48 30 17 91 130
2022/20231.480 111 265 68 141 114 262 174 84 174 7 31 49
2023/2024617 21 55 79 16 32 67 82 157 15 21 43 29
2024/20252.286 135 361 242 591 957 0 0 0 0 0 0 0
Totale 8.408